The Agile Drug Discovery Company
Synfini will dramatically reduce the time and cost of modern molecular discovery by uniting physical and virtual chemistry through expert-curated AI and discovery-focused robotic automation, leading to the most dynamic synthesis data and designer molecules.
The Platform
- Fast – Provides drug hunters with the fastest path to novel, patentable molecules.
- Open – Agnostic to the source of hits or bioassay data, elegantly advances starting points from any Generative AI, Modeling, HTS, or other system.
- Efficient – Reduce spiraling hosting and offshoring costs by culling erroneous designs, GPU hosting costs, and more.
- Green – Protect the environment by eliminating 90% of electricity demands.
- Optimal – Balances the contribution of virtual design, physical design, and human-directed
Press Releases
The Goal: Make drug discovery less expensive and more efficient.
By uniting physical and virtual chemistry through expert-curated AI and discovery-focused robotic automation, leading to the most dynamic synthesis data and designer molecules.
A suite of hardware solutions, combined with cutting-edge AI technologies, holds great promise for accelerating the speed at which biopharma companies can develop new therapeutics — and for creating a healthier future for all.
Synfini will:
- Dramatically accelerate drug discovery
- Help drug hunters looking for superior, faster, lower-cost exploration of chemical space
- Discover optimized molecules and the ability to easily pivot based on evolving biology and personalized medicine requirements
- Improve drug licensing value
- Help pharma companies that are under regulatory pressure, and to find cost efficiencies and address previously underserved ‘niche’ markets more effectively